OrthoPediatrics holder sells 337K shares at ~$23

Rhea-AI Filing Summary

ORTHOPEDIATRICS CORP (KIDS) reported that Squadron Capital LLC, a ten percent owner, sold a total of 336,831 shares of common stock in two open-market transactions. On August 28, 2026 it sold 326,700 shares at a weighted average price of $23.04 per share, with individual prices ranging from $23.00 to $23.82. On September 1, 2026 it sold 10,131 shares at a weighted average price of $23.10, with individual prices ranging from $23.00 to $23.58. The footnotes state the sale by Squadron Capital LLC was undertaken to provide additional capital for its other portfolio businesses, and that Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

Insider Trade Summary

Net Seller: 336,831 shares

Net Sell 2 txns

Insider Squadron Capital LLC, Squadron Capital Holdings LLC

Role 10% Owner | 10% Owner

Sold 336,831 shs ($7.76M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F4, F3	10,131	$23.10	$234K
Sale	Common Stock F1, F2, F3	326,700	$23.04	$7.53M

Holdings After Transaction: Common Stock — 6,526,633 shares (Direct)

Footnotes (4)

1. F1. This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. F3. These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.
4. F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Key Figures

Shares sold (August 28, 2026): 326,700 shares Weighted average price (August 28, 2026): $23.04 per share Shares sold (September 1, 2026): 10,131 shares +2 more

5 metrics

Shares sold (August 28, 2026) 326,700 shares Common Stock sold by Squadron Capital LLC on 2026-08-28

Weighted average price (August 28, 2026) $23.04 per share Sales executed within a $23.00–$23.82 price range

Shares sold (September 1, 2026) 10,131 shares Common Stock sold by Squadron Capital LLC on 2026-09-01

Weighted average price (September 1, 2026) $23.10 per share Sales executed within a $23.00–$23.58 price range

Total shares sold 336,831 shares Net shares sold across both reported transactions

Key Terms

weighted average price, ten percent owner, controlling member, portfolio businesses

4 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

ten percent owner regulatory

"Squadron Capital LLC and Squadron Capital Holdings LLC are each a ten percent owner."

controlling member financial

"Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC."

portfolio businesses financial

"to provide additional capital for its other portfolio businesses."

FAQ

Who sold shares of ORTHOPEDIATRICS CORP (KIDS) in this Form 4 filing?

The filing reports sales by Squadron Capital LLC, a ten percent owner of ORTHOPEDIATRICS CORP, with Squadron Capital Holdings LLC identified as the controlling member of Squadron Capital LLC. The securities are held directly by Squadron Capital LLC.

How many KIDS shares did Squadron Capital LLC sell in total?

Squadron Capital LLC sold a total of 336,831 shares of ORTHOPEDIATRICS CORP common stock, consisting of 326,700 shares sold on August 28, 2026 and 10,131 shares sold on September 1, 2026.

What prices were the KIDS shares sold for in these transactions?

The reported prices are weighted average prices. On August 28, 2026, shares were sold at a weighted average of $23.04 within a $23.00–$23.82 range. On September 1, 2026, shares were sold at a weighted average of $23.10 within a $23.00–$23.58 range.

Why did Squadron Capital LLC sell KIDS shares according to the filing?

A footnote states that the sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. This stated purpose relates to Squadron Capital’s broader investment activities rather than to ORTHOPEDIATRICS CORP’s operations.

Were the KIDS share sales made under a Rule 10b5-1 trading plan?

The document-level Rule 10b5-1 checkbox is unchecked (aff_10b5_one is false), and the footnotes do not state that the sales were made pursuant to a Rule 10b5-1 trading plan.

Does the Form 4 show remaining KIDS holdings for Squadron Capital LLC after the sales?

The transaction rows report no share balance in the "shares following transaction" field, and this Form 4 does not list any separate holding entries, so remaining share ownership is not quantified here.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 06:49 PM Accepted by SEC EDGAR 09/01/2026 - 06:48 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Squadron Capital LLC

(Last) (First) (Middle)

18 HARTFORD AVE., PO BOX 223

(Street)

GRANBY CONNECTICUT 06035

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/28/2026		S(1)		326,700	D	$23.04(2)	6,536,764	D(3)
Common Stock	09/01/2026		S(1)		10,131	D	$23.1(4)	6,526,633	D(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Squadron Capital LLC

(Last) (First) (Middle)

18 HARTFORD AVE., PO BOX 223

(Street)

GRANBY CONNECTICUT 06035

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Squadron Capital Holdings LLC

(Last) (First) (Middle)

104 S. MICHIGAN AVE.

(Street)

CHICAGO ILLINOIS 60603

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

	/s/ David R. Pelizzon, President of Squadron Capital LLC	09/01/2026
	/s/ Mary Falcon, Manager of Squadron Capital Holdings LLC	09/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)